Dissemination and Implementation Science (D&I) in health is a pivotal discipline within evidence-based healthcare, focusing on bridging the gap between research findings and their practical application in real-world healthcare settings. D&I science strives to accelerate the integration of proven interventions into routine practice, ensuring that the benefits of evidence-based approaches reach a broader population.
In evidence-based healthcare, D&I science acts as a catalyst for transforming research into actionable strategies. It involves developing effective communication channels, strategies, and frameworks to disseminate research findings and implement evidence-based practices in diverse healthcare environments.
This discipline plays a crucial role in optimizing the translation of research evidence into tangible improvements in patient care. By addressing barriers and facilitators to implementation, D&I science contributes to the successful adoption of evidence-based interventions, promoting a culture of continuous learning and improvement within the healthcare ecosystem. Ultimately, the goal is to enhance the quality, efficiency, and impact of healthcare by ensuring that evidence-based knowledge is effectively disseminated and translated into practice.
Title : Overview of augmented intelligence for nursing
Adele Webb, Strategic Education, Inc., United States
Title : Equity in action: Amplifying your voice in nursing leadership
Robin Adams Geiger, Ingenovis Health, United States
Title : The relationship between empowerment and quality of health among clients with chronic health conditions
Ismat Mikky, Bloomfield College of Montclair State University, United States
Title : Healthcare system sponsored CNA training program creates opportunity and increases workforce
John R Balcuk, Northwell Health Huntington Hospital, United States
Title : Pathway-Aligned degrees: A strategic solution to the global nursing shortage
Maureen Kroning, SUNY Empire State University, United States
Title : The importance of assessing the patient experience of hypersensitivity reaction
Kerry Hennessy, Dana Farber Cancer Institute, United States